Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 39217-08-8 Chemical Structure| 39217-08-8

Structure of 39217-08-8

Chemical Structure| 39217-08-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 39217-08-8 ]

CAS No. :39217-08-8
Formula : C5H6ClN3
M.W : 143.57
SMILES Code : NC1=C(N)C=CN=C1Cl
MDL No. :MFCD07363739
InChI Key :PWOIYBVEDIFBEO-UHFFFAOYSA-N
Pubchem ID :285736

Safety of [ 39217-08-8 ]

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H301-H319-H317
Precautionary Statements:P501-P261-P272-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P333+P313-P301+P310+P330-P405
Class:6.1
UN#:2811
Packing Group:

Computational Chemistry of [ 39217-08-8 ] Show Less

Physicochemical Properties

Num. heavy atoms 9
Num. arom. heavy atoms 6
Fraction Csp3 0.0
Num. rotatable bonds 0
Num. H-bond acceptors 1.0
Num. H-bond donors 2.0
Molar Refractivity 38.06
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

64.93 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

0.78
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

0.45
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

0.92
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

-0.21
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

0.63
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

0.51

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-1.51
Solubility 4.47 mg/ml ; 0.0311 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-1.38
Solubility 5.96 mg/ml ; 0.0415 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-1.9
Solubility 1.81 mg/ml ; 0.0126 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

No
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.86 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

1.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.69

Application In Synthesis of [ 39217-08-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 39217-08-8 ]

[ 39217-08-8 ] Synthesis Path-Downstream   1~1

  • 1
  • [ 39217-08-8 ]
  • [ 1258298-01-9 ]
  • C12H6Cl2IN3O [ No CAS ]
YieldReaction ConditionsOperation in experiment
With polyphosphoric acid; at 190℃; for 3.0h; General procedure: A mixture of 2-chloropyridine-3,4-diamine(2.80 g, 19.4mmol), 2,6-dichlorobenzoic acid(3.71 g, 19.4mmol)andpolyphosphoricacid (50 g) was heated at 190 Cfor 3 h with stirring. The mixture was cooled to room temperature and poured into ice/water. The resulting mixture was neutralized by addition of aq. saturated Na2CO3solution. The crude product was collected by filtration, washed with water, and dried to afford a brown solid(5.4 g, 97% yield).1H NMR(DMSO-d6, 500 MHz):delta13.08 (s, 1H), 11.21 (s, 1H), 7.67-7.58 (m, 3H),7.15 (m, 1H), 6.49 (d,J= 7.0 Hz, 1H).LCMS(ESI) m/z: 280.0 [M+H+].
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 39217-08-8 ]

Chlorides

Chemical Structure| 5632-81-5

A303095 [5632-81-5]

2-Chloropyridine-3,5-diamine

Similarity: 0.92

Chemical Structure| 50432-67-2

A154302 [50432-67-2]

2-Chloro-N4-methylpyridine-3,4-diamine

Similarity: 0.91

Chemical Structure| 6298-19-7

A343231 [6298-19-7]

2-Chloropyridin-3-amine

Similarity: 0.88

Chemical Structure| 18232-91-2

A155577 [18232-91-2]

2-Chloro-5-methylpyridine-3,4-diamine

Similarity: 0.84

Chemical Structure| 101079-63-4

A197570 [101079-63-4]

2,6-Dichloropyridine-3,4-diamine

Similarity: 0.81

Amines

Chemical Structure| 5632-81-5

A303095 [5632-81-5]

2-Chloropyridine-3,5-diamine

Similarity: 0.92

Chemical Structure| 50432-67-2

A154302 [50432-67-2]

2-Chloro-N4-methylpyridine-3,4-diamine

Similarity: 0.91

Chemical Structure| 6298-19-7

A343231 [6298-19-7]

2-Chloropyridin-3-amine

Similarity: 0.88

Chemical Structure| 18232-91-2

A155577 [18232-91-2]

2-Chloro-5-methylpyridine-3,4-diamine

Similarity: 0.84

Chemical Structure| 101079-63-4

A197570 [101079-63-4]

2,6-Dichloropyridine-3,4-diamine

Similarity: 0.81

Related Parent Nucleus of
[ 39217-08-8 ]

Pyridines

Chemical Structure| 5632-81-5

A303095 [5632-81-5]

2-Chloropyridine-3,5-diamine

Similarity: 0.92

Chemical Structure| 50432-67-2

A154302 [50432-67-2]

2-Chloro-N4-methylpyridine-3,4-diamine

Similarity: 0.91

Chemical Structure| 6298-19-7

A343231 [6298-19-7]

2-Chloropyridin-3-amine

Similarity: 0.88

Chemical Structure| 18232-91-2

A155577 [18232-91-2]

2-Chloro-5-methylpyridine-3,4-diamine

Similarity: 0.84

Chemical Structure| 101079-63-4

A197570 [101079-63-4]

2,6-Dichloropyridine-3,4-diamine

Similarity: 0.81